Perry, M.J.; Centurioni, D.A.; Davis, S.W.; Hannett, G.E.; Musser, K.A.; Egan, C.T.
Implementing the Bruker MALDI Biotyper in the Public Health Laboratory for C. botulinum Neurotoxin Detection. Toxins 2017, 9, 94.
https://doi.org/10.3390/toxins9030094
AMA Style
Perry MJ, Centurioni DA, Davis SW, Hannett GE, Musser KA, Egan CT.
Implementing the Bruker MALDI Biotyper in the Public Health Laboratory for C. botulinum Neurotoxin Detection. Toxins. 2017; 9(3):94.
https://doi.org/10.3390/toxins9030094
Chicago/Turabian Style
Perry, Michael J., Dominick A. Centurioni, Stephen W. Davis, George E. Hannett, Kimberlee A. Musser, and Christina T. Egan.
2017. "Implementing the Bruker MALDI Biotyper in the Public Health Laboratory for C. botulinum Neurotoxin Detection" Toxins 9, no. 3: 94.
https://doi.org/10.3390/toxins9030094
APA Style
Perry, M. J., Centurioni, D. A., Davis, S. W., Hannett, G. E., Musser, K. A., & Egan, C. T.
(2017). Implementing the Bruker MALDI Biotyper in the Public Health Laboratory for C. botulinum Neurotoxin Detection. Toxins, 9(3), 94.
https://doi.org/10.3390/toxins9030094